Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Equity Ratio: 2021-2025

Historic Equity Ratio for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to 1.00.

  • Molecular Partners Ag's Equity Ratio changed negligibly% to 1.00 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.00, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 1.00 for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Molecular Partners Ag reported Equity Ratio of 1.00 as of Q3 2025, which was down 0.00% from 1.00 recorded in Q2 2025.
  • Molecular Partners Ag's 5-year Equity Ratio high stood at 3.43 for Q2 2024, and its period low was 1.00 during Q4 2021.
  • Moreover, its 3-year median value for Equity Ratio was 1.00 (2025), whereas its average is 1.22.
  • Per our database at Business Quant, Molecular Partners Ag's Equity Ratio soared by 242.87% in 2024 and then plummeted by 70.83% in 2025.
  • Quarterly analysis of 5 years shows Molecular Partners Ag's Equity Ratio stood at 1.00 in 2021, then remained steady at 1.00 in 2022, then remained steady at 1.00 in 2023, then remained steady at 1.00 in 2024, then remained steady at 1.00 in 2025.
  • Its Equity Ratio stands at 1.00 for Q3 2025, versus 1.00 for Q2 2025 and 1.00 for Q1 2025.